BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16411205)

  • 1. Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles.
    Burniston JG; Clark WA; Tan LB; Goldspink DF
    Muscle Nerve; 2006 May; 33(5):655-63. PubMed ID: 16411205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic effects of a non-myotoxic dose of the beta2-adrenergic receptor agonist clenbuterol on rat plantaris muscle.
    Burniston JG; McLean L; Beynon RJ; Goldspink DF
    Muscle Nerve; 2007 Feb; 35(2):217-23. PubMed ID: 17058275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle.
    Burniston JG; Tan LB; Goldspink DF
    J Appl Physiol (1985); 2005 Apr; 98(4):1379-86. PubMed ID: 15591297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotoxic effects of clenbuterol in the rat heart and soleus muscle.
    Burniston JG; Ng Y; Clark WA; Colyer J; Tan LB; Goldspink DF
    J Appl Physiol (1985); 2002 Nov; 93(5):1824-32. PubMed ID: 12381771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol.
    Burniston JG; Chester N; Clark WA; Tan LB; Goldspink DF
    Muscle Nerve; 2005 Dec; 32(6):767-74. PubMed ID: 16007677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.
    Murphy RJ; Béliveau L; Gardiner PF; Calderone A
    Proc Soc Exp Biol Med; 1999 Jul; 221(3):184-7. PubMed ID: 10404034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
    George I; Xydas S; Mancini DM; Lamanca J; DiTullio M; Marboe CC; Shane E; Schulman AR; Colley PM; Petrilli CM; Naka Y; Oz MC; Maybaum S
    J Heart Lung Transplant; 2006 Sep; 25(9):1084-90. PubMed ID: 16962470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes.
    Petrou M; Wynne DG; Boheler KR; Yacoub MH
    Circulation; 1995 Nov; 92(9 Suppl):II483-9. PubMed ID: 7586459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a low dose of clenbuterol on rat soleus muscle submitted to joint immobilization.
    Cancelliero KM; Durigan JL; Vieira RP; Silva CA; Polacow ML
    Braz J Med Biol Res; 2008 Dec; 41(12):1054-8. PubMed ID: 19148366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
    Suzuki J; Gao M; Xie Z; Koyama T
    Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor.
    Hinkle RT; Hodge KMB; Cody DB; Sheldon RJ; Kobilka BK; Isfort RJ
    Muscle Nerve; 2002 May; 25(5):729-734. PubMed ID: 11994968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
    Bricout VA; Serrurier BD; Bigard AX
    Acta Physiol Scand; 2004 Mar; 180(3):271-80. PubMed ID: 14962009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β₂-adrenergic agonist.
    Abo T; Iida RH; Kaneko S; Suga T; Yamada H; Hamada Y; Yamane A
    Cell Biochem Funct; 2012 Dec; 30(8):671-6. PubMed ID: 22696074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats].
    Rehfeldt C; Weikard R; Reichel K
    Arch Tierernahr; 1994; 45(4):333-44. PubMed ID: 7487480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration.
    Moore NG; Pegg GG; Sillence MN
    Am J Physiol; 1994 Sep; 267(3 Pt 1):E475-84. PubMed ID: 7943228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.
    Ryall JG; Gregorevic P; Plant DR; Sillence MN; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2002 Dec; 283(6):R1386-94. PubMed ID: 12388476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats.
    Burniston JG; Tan LB; Goldspink DF
    Exp Physiol; 2006 Nov; 91(6):1041-9. PubMed ID: 16973691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clenbuterol reduces soleus muscle fatigue during disuse in aged rats.
    Chen KD; Alway SE
    Muscle Nerve; 2001 Feb; 24(2):211-22. PubMed ID: 11180204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment.
    von Deutsch DA; Abukhalaf IK; Wineski LE; Silvestrov NA; Bayorh MA; Potter DE
    Can J Physiol Pharmacol; 2003 Jan; 81(1):28-39. PubMed ID: 12665255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural findings for the mitochondrial subpopulation of mice skeletal muscle after adrenergic stimulation by clenbuterol.
    Sundal S; Sharma S
    J Physiol Sci; 2007 Feb; 57(1):7-14. PubMed ID: 17169166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.